In the article, “Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review” [1] which appears in Volume 11, Issue 10 of Nutrients, there is a correction on the official term of the drug name used in the article.
As De Simone [2] points out, The drug term VSL#3® is replaced with the generic name of the formulation, “De Simone formulation”, following a legal dispute between the distributors of the product VSL#3® and the formula inventor.
This change does not affect the study of the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Picó-Monllor J.A., Mingot-Ascencao J.M. Search and selection of probiotics that improve mucositis symptoms in oncologic patients: A systematic review. Nutrients. 2019;11:2322. doi: 10.3390/nu11102322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.De Simone C. Comment on: “Search and selection of probiotics that improve mucositis symptoms in oncologic patients: A systematic review. Nutrients 2019, 11, 2322”. Nutrients. 2020;12:399. doi: 10.3390/nu12020399. [DOI] [PMC free article] [PubMed] [Google Scholar]